Sex differences according to ethnic presentation in carotid body tumors: a systematic literature review

Authors

  • Kuauhyama Luna-Ortiz Department of Head and Neck Surgery, Instituto Nacional de Cancerología, Mexico http://orcid.org/0000-0002-1862-4036
  • Nancy Reynoso-Noverón Research Statistical Department, Instituto Nacional de Cancerología, Mexico
  • Cesar Herrera-Ponzanelli Department of Head and Neck Surgery, Instituto Nacional de Cancerología, Mexico
  • Saul Favila-Lira Department of Head and Neck Surgery, Instituto Nacional de Cancerología, Mexico
  • Zelik Luna-Peteuil Universitatea de Medicinâ si Farmacie Grigorie T. Popa IASI, Rumania
  • Angel Herrera-Gomez Department of Surgical Oncology, Instituto Nacional de Cancerología, Mexico
  • Dorian Y. Gacia-Ortega Department of Surgical Oncology, Instituto Nacional de Cancerología, Mexico

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20221393

Keywords:

Systematic review, Carotid body tumor, Carotid body paraganglioma, Head and neck paraganglioma, Paraganglioma

Abstract

Compare through a systematic literature review, the sex distribution of patients with carotid body tumors in Mexico and Latin America with the rest of the world. The eligibility criteria included retrospective cohort studies of more than 15 patients with a diagnosis of carotid body tumor (regardless of Shamblin's classification or clinical manifestations), which also reported the number of women and men affected, as well as their mean age. We divided the countries where the studies were conducted into regions (Latin America, USA, and Europe/Asia). The sex ratio difference between regions was calculated using a chi-square test. A p<0.05 was considered statistically significant. Thirty-eight studies met the eligibility criteria. Latin America had 1,345 cases, the United States had 808, and Europe/Asia had 672. Mexico had the most cases (1125), followed by the United States. The rest of the countries had less than 30 cases each. We found a statistically significant differences when we compared Latin American countries with the United States and Europe/ Asia (p<0.001). However, the most significant difference was observed when we compared Mexico with the United States, Europe/Asia, and other Latin American countries. When comparing other Latin American countries with Europe/Asia, we found a statistical difference (p=0.01); however, there was no statistical difference (p=0.05) when we compared other Latin American countries with the United States. Mexico has the highest number of reported cases of carotid body tumors in the world. Women account for 90% of cases.

Metrics

Metrics Loading ...

References

Demattè S, Di Sarra D, Schiavi F, Casadei A, Opocher G. Role of ultrasound and color Doppler imaging in the detection of carotid paragangliomas. J Ultrasound. 2012;15(3):158-63.

Rodríguez-Cuevas S, López-Garza J, Labastida-Almendaro S. Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level. Head Neck. 1998;20(5):374-8.

Luna-Ortiz K, Rascon-Ortiz M, Villavicencio-Valencia V, Granados-Garcia M, Herrera-Gomez A. Carotid body tumors: Review of a 20-year experience. Oral Oncol. 2005;41(1):56-61.

Bizueto-Rosas H, Gutiérrez-Vogel S, Hernández-Salgado R, López-Silva J, Enríquez-Vega ME, Cossío-Zazueta A et al. Carotid Paraganglioma. Experience of a Reference Center, UMAE Hospital De Especialidades Del Centro Médico Nacional “La Raza”, 964 Cases in 32 Years. J Surg Open Access. 2020;6(3).

Elizabeth Enríquez-Vega M, Gabriela Muñoz-Paredes J, Cossío-Zazueta A, Ontiveros-Carlos Y, Pacheco-Pittaluga E, Bizueto-Rosas H. Mutación del gen SDHD en población mexicana con tumor del cuerpo carotídeo SDHD gene mutation in Mexican population whit carotid body tumor. Cir Cir. 2018;86(1):38-42.

Fruhmann J, Geigl JB, Konstantiniuk P, Cohnert TU. Paraganglioma of the carotid body: Treatment strategy and SDH-gene mutations. Eur J Vasc Endovasc Surg. 2013;45(5):431-6.

Kudryavtseva AV, Lukyanova EN, Kalinin DV, Zaretsky AR, Pokrovsky AV, Golovyuk AL et al. Mutational load in carotid body tumor. BMC Med Genomics. 2019;12(2).

Atefi S, Nikeghbalian S, Yarmohammadi H, Assadi-Sabet A. Surgical management of carotid body tumours: A 24-year surgical experience. ANZ J Surg. 2006;76:214-7.

Bishop GB, Urist MM, Gammal T El, Peters GE, Maddox WA. Paragangliomas of the Neck. Arch Surg. 1992;127(12):1441-5.

Cobb AN, Barkat A, Daungjaiboon W, Halandras P, Crisostomo P, Kuo PC et al. Carotid Body Tumor Resection: Just as Safe without Preoperative Embolization. Ann Vasc Surg. 2018;46:54-9.

Casarim ALM, Tincani AJ, Del Negro A, Aguiar CG, Fanni RV, Martins AS. Tumor de corpo carotídeo: Análise retrospectiva de 22 pacientes. Sao Paulo Med J. 2014;132(3):133-9.

Rafael Gutiérrez-Carreño A, Sánchez-Fabela C, Gutiérrez-Carreño AB, Patricia Portillo-Fernández D, Lizola-Margolis RI, Mónica Mendieta-Hernández D. Paraganglioma carotídeo. Actualidades 2012. Experiencia de 35 años. Revista Mexicana de angiologia. 2012;40.

Patetsios P, Gable DR, Garrett W V, Lamont JP, Kuhn JA, Shutze WP et al. Management of carotid body paragangliomas and review of a 30-year experience. Ann Vasc Surg. 2002;16(3):331-8.

Gwon JG, Kwon TW, Kim H, Cho YP. Risk factors for stroke during surgery for carotid body tumors. World J Surg. 2011;35(9):2154-8.

Boscarino G, Parente E, Minelli F, Ferrante A, Snider F. An evaluation on management of carotid body tumour (CBT). A twelve years experience. G di Chir. 2014;35(1-2):47-51.

Paridaans MPM, Van Der Bogt KEA, Jansen JC, Nyns ECA, Wolterbeek R, Van Baalen JM et al. Results from craniocaudal carotid body tumor resection: Should it be the standard surgical approach? Eur J Vasc Endovasc Surg. 2013;46(6):624-9.

Inan HC, Yener HM, Karaman E, Kizilkiliç O, Cansiz H, Eker Ç. Role of preoperative embolization in surgical treatment of the carotid body paragangliomas. J Craniofac Surg. 2019;30(3):E267-70.

Javid H, Chawla SK, Dye WS, Hunter JA, Najafi H, Goldin MD et al. Carotid Body Tumor: Resection or Reflection. Arch Surg. 1976;111(4):344-7.

Kraus DH, Sterman BM, Hakaim AG, Beven EG, Levine HL, Wood BG. Carotid Body Tumors. Arch Otolaryngol Neck Surg. 1990;116(12):1384-7.

Lack EE, Cubilla AL, Woodruff JM, Farr HW. Paragangliomas of the head and neck region. A clinical study of 69 patients. Cancer. 1977;39(2):397-409.

Lamblin E, Atallah I, Reyt E, Schmerber S, Magne JL, Righini CA. Neurovascular complications following carotid body paraganglioma resection. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133(5):319-24.

O[apos ]Donnell TF, LaMuraglia GM, Fabian RL, Brewster DC, Pile-Spellman JC, Darling RC et al. The current surgical management of carotid body paragangliomas. J Vasc Surg. 1992;15(6):1038-45.

Lees CD, Levine HL, Beven EG, Tucker HM. Tumors of the carotid body. Experience with 41 operative cases. Am J Surg. 1981;142(3):362-5.

Muhm M, Polterauer P, Gstöttner W, Temmel A, Richling B, Undt G et al. Diagnostic and therapeutic approaches to carotid body tumors: Review of 24 patients. Arch Surg. 1997;132(3):279-84.

Sajid MS, Hamilton G, Baker DM, on behalf of Joint Vascular Research Group. A Multicenter Review of Carotid Body Tumour Management. Eur J Vasc Endovasc Surg; 2007;34:127-30.

Netterville JL, Reilly KM, Robertson D, Reiber ME, Armstrong WB, Childs P. Carotid body tumors: A review of 30 patients with 46 tumors. Laryngoscope. 1995;105(2):115-26.

Pacheco-Ojeda L, Durango E, Rodriquez C, Vivar N. Carotid body tumors at high altitudes: Quito, Ecuador, 1987. World J Surg. 1988;12(6):856-9.

Papaspyrou K, Mann WJ, Amedee RG. Management of head and neck paragangliomas: Review of 120 patients. Head Neck. 2009;31(3):381-7.

Saldana MJ, Salem LE, Travezan R. High altitude hypoxia and chemodectomas. Hum Pathol. 1973;4(2):251-63.

Silva A, Tapia R. Paraganglioma de cuerpo carotideo. Rev la Fac Ciencias Médicas. 2017;42(2):134-9.

Sanghvi VD, Chandawarkar RY. Carotid body tumors. J Surg Oncol. 1993;54(3):190-2.

Ünlü Y, Becit N, Ceviz M, Koçak H. Management of Carotid Body Tumors and Familial Paragangliomas: Review of 30 Years’ Experience. Ann Vasc Surg. 2009;23(5):616-20.

Williams MD, Phillips MJ, Nelson WR, Rainer WG. Carotid Body Tumor. Arch Surg. 1992;127(8):963-8.

Dorobisz K, Dorobisz T, Temporale H, Zatoński T, Kubacka M, Chabowski M et al. Diagnostic and therapeutic difficulties in carotid body paragangliomas, based on clinical experience and a review of the literature. Adv Clin Exp Med. 2016;25(6):1173-7.

Anand VK, Alemar GO, Sanders TS. Management of the internal carotid artery during carotid body tumor surgery. Laryngoscope. 1995;105(3):231-5.

Al-Harthy M, Al-Harthy S, Al-Otieschan A, Velagapudi S, Alzahrani AS. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas. Endocr Pract. 2009;15(3):194-202.

Lechter A, Naar JD, Andrade O. Paragangliomas del cuerpo carotídeo. Rev colomb cir. 1992;86-9.

Amato B, Bianco T, Compagna R, Siano M, Esposito G, Buffone G et al. Surgical resection of carotid body paragangliomas: 10 years of experience. Am J Surg. 2014;207(2):293-8.

Anderson R, Scarcella JV. Carotid body tumors. Am J Surg. 1963;106(5):856-9.

Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genetics. 2002;39:617-22.

Mhatre AN, Li Y, Feng L, Gasperin A, Lalwani AK. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas. Clin Genet. 2004;66(5):461-6.

Lee JH, Barich F, Karnell LH, Robinson RA, Zhen WK, Gantz BJ et al. National cancer data base report on malignant paragangliomas of the head and neck. Cancer. 2002;94(3):730-7.

Feinstein AR, Sosin DM, Wells CK. The Will Rogers Phenomenon. N Engl J Med. 1985;312(25):1604-8.

Downloads

Published

2022-05-25

Issue

Section

Systematic Reviews